Last reviewed · How we verify
BENZOYL PEROXIDE/ ADAPALENE — Competitive Intelligence Brief
marketed
Retinoid + peroxide combination
Retinoic acid receptors (adapalene); bacterial cell oxidative stress (benzoyl peroxide)
Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
BENZOYL PEROXIDE/ ADAPALENE (BENZOYL PEROXIDE/ ADAPALENE) — Stiefel, a GSK Company. Benzoyl peroxide kills acne-causing bacteria and promotes skin cell turnover, while adapalene normalizes skin cell differentiation and reduces inflammation.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| BENZOYL PEROXIDE/ ADAPALENE TARGET | BENZOYL PEROXIDE/ ADAPALENE | Stiefel, a GSK Company | marketed | Retinoid + peroxide combination | Retinoic acid receptors (adapalene); bacterial cell oxidative stress (benzoyl peroxide) | |
| adapalene/benzoyl peroxide | adapalene/benzoyl peroxide | Galderma R&D | marketed | Retinoid + peroxide combination | Retinoic acid receptors (adapalene); bacterial cell membrane and proteins (benzoyl peroxide) | |
| Adapalene/Benzoyl Peroxide Gel 0.3-2.5% | Adapalene/Benzoyl Peroxide Gel 0.3-2.5% | Derm Research, PLLC | marketed | Retinoid + peroxide combination | Retinoic acid receptors (adapalene); bacterial cell membrane and proteins (benzoyl peroxide) | |
| Adapalene + benzoyl peroxide samples | Adapalene + benzoyl peroxide samples | Wake Forest University | marketed | Retinoid + peroxide combination | Retinoic acid receptors (adapalene); bacterial cell membrane and proteins (benzoyl peroxide) | |
| Epiduo® Gel right face | Epiduo® Gel right face | GWT-TUD GmbH | marketed | Retinoid + peroxide combination | Retinoic acid receptor (adapalene); bacterial cell membrane disruption (benzoyl peroxide) | |
| Adapalene-BPO Gel | Adapalene-BPO Gel | Galderma Brasil Ltda. | marketed | Retinoid + peroxide combination | Retinoic acid receptors (adapalene); bacterial cell membrane and proteins (benzoyl peroxide) | |
| Adapalene/benzoyl peroxide gel, 0.1%/2.5% | Adapalene/benzoyl peroxide gel, 0.1%/2.5% | Galderma R&D | marketed | Retinoid + peroxide combination | Retinoic acid receptors (adapalene); bacterial cell membrane and proteins (benzoyl peroxide) |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Retinoid + peroxide combination class)
- Galderma R&D · 5 drugs in this class
- GWT-TUD GmbH · 1 drug in this class
- Galderma Brasil Ltda. · 1 drug in this class
- Derm Research, PLLC · 1 drug in this class
- Padagis LLC · 1 drug in this class
- Stiefel, a GSK Company · 1 drug in this class
- Wake Forest University · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- BENZOYL PEROXIDE/ ADAPALENE CI watch — RSS
- BENZOYL PEROXIDE/ ADAPALENE CI watch — Atom
- BENZOYL PEROXIDE/ ADAPALENE CI watch — JSON
- BENZOYL PEROXIDE/ ADAPALENE alone — RSS
- Whole Retinoid + peroxide combination class — RSS
Cite this brief
Drug Landscape (2026). BENZOYL PEROXIDE/ ADAPALENE — Competitive Intelligence Brief. https://druglandscape.com/ci/benzoyl-peroxide-adapalene. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab